Save time and get answers to complex questions with AI chat
Is clarinex off patent?Complera manufacturer?Prolia and osteonecrosis?Stribild expiry date?Is guselkumab off patent in u s?
See the DrugPatentWatch profile for Syfovre
Syfovre (pegcetacoplan) received FDA approval on May 17, 2023.[1]
Syfovre was approved for the treatment of geographic atrophy secondary to age-related macular degeneration (AMD) in adults.[1]
DrugPatentWatch.com maintains drug coverage that includes regulatory timelines such as approvals.[1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Syfovre :